[Form 4] ABBOTT LABORATORIES Insider Trading Activity

Rhea-AI Filing Summary

Robert J. Alpern, a director of Abbott Laboratories (ABT), reported a transaction dated 09/30/2025 on a Form 4. The filing shows an acquisition of 58 common share equivalents recorded at $133.94 per share and a post-transaction beneficial balance of 10,300 stock-equivalent units. The filing notes these units represent director fees credited to a grantor trust that mirror Abbott share returns and are generally paid in cash at age 65 or upon board retirement; the balance also includes units from a dividend reinvestment feature. The Form 4 was signed on behalf of Mr. Alpern by an attorney-in-fact on 10/02/2025.

Positive

• 58 common share equivalents were acquired, demonstrating continued director compensation alignment with shareholders
• Post-transaction balance of 10,300 stock-equivalent units shows meaningful existing indirect ownership
• Stock-equivalent units "earn the same return" as Abbott shares, aligning director economic interests with shareholders

Negative

• None.

Insights

Corporate Governance Analyst

Director received stock-equivalent director fees totaling 10,300 units, with a 58-unit accrual on 09/30/2025.

The Form 4 shows director compensation being credited as stock-equivalent units rather than immediate stock or cash. This aligns compensation with shareholder returns because the units "earn the same return" as Abbott shares, preserving long-term alignment with shareholders.

The filing discloses the plan's payout timing—generally at age 65 or upon board retirement—which is a defined distribution feature rather than an immediate equity grant.

Insider Compliance Expert

Reported acquisition of 58 common share equivalents at $133.94 on 09/30/2025, Form 4 filed and signed 10/02/2025.

The transaction code indicates an acquisition tied to director compensation, not a market purchase, and the filing was executed by an attorney-in-fact, which is permitted under Section 16 filing rules. The entry shows a post-transaction beneficial ownership of 10,300 units, clarifying the director's ongoing indirect interest.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Alpern Robert J

(Last) (First) (Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK IL 60064

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Equivalent Units	(1)	09/30/2025		A		58		(1)	(1)	Common Shares	58	$133.94	10,300(2)	D

Explanation of Responses:

1. Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

2. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

	/s/ Robert J. Alpern by Jessica H. Paik, Attorney-in-Fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Robert J. Alpern report on the Form 4 for ABT?

He reported an acquisition of 58 common share equivalents dated 09/30/2025, recorded at $133.94 per share, with a post-transaction balance of 10,300 units.

Are the reported units actual Abbott shares or a different vehicle?

They are stock-equivalent units credited under a grantor trust that "earn the same return" as Abbott shares and are generally paid in cash at age 65 or upon retirement.

When was the Form 4 for ABT signed and who signed it?

The form was signed on behalf of Robert J. Alpern by an attorney-in-fact, Jessica H. Paik, on 10/02/2025.

Does the Form 4 show direct or indirect ownership?

The filing indicates the holdings are in an indirect form as stock-equivalent units under a grantor trust; the post-transaction balance is 10,300 units.

What triggers payout of the stock-equivalent units?

The filing states the units are generally paid in cash at age 65 or upon retirement from the board.